ReShape Lifesciences 以每单位 2.33 美元的价格推出 $6M 股票发行，定于 2 月 18 日结束。 ReShape Lifesciences launches $6M stock offering at $2.33 per unit, set to close on Feb. 18.

一家提供减重和新陈代谢保健解决方案的公司 " 重建生命科学 " 宣布,以每单位2.33美元的价格公开出价,总价为600万美元。 ReShape Lifesciences, a company offering weight loss and metabolic health solutions, has announced a public offering priced at $2.33 per unit, totaling $6 million. 每个单位包括一个共同份额和购买另一个共同份额的许可令,授权书可在股东批准后执行。 Each unit includes one common share and a warrant to buy another common share, with warrants exercisable upon stockholder approval. 该交易预计将于2025年2月18日结束,由Maxim Group LLC管理. The offering, expected to close on February 18, 2025, is being managed by Maxim Group LLC.